Male Breast Carcinoma — Trials

Male Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

104 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01938833	Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer	terminated	Phase 1 / Phase 2	9	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	May 16, 2025	clinicaltrials
NCT01217411	RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer	terminated	Phase 1 / Phase 2	5	National Cancer Institute (NCI)NIH	1